(Yicai) June 25 -- Shares of Fosun Pharmaceutical Group rose after the Chinese drug giant's unit Fosun New Drug inked a deal to fully acquire Henlius Biotech for up to HKD5.4 billion (USD691.7 million) in cash and/or shares. Fosun Pharma [HKG: 2196] jumped 4.5 percent to HKD13.44 (USD1.72) a share as of 10.20 a.m. in Hong Kong today. Its Shanghai-listed stock [SHA: 600196] climbed 1.1 percent to CNY22.16 (USD3.05).
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Chen
Contact Chen, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack